Search results
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.
- Michele B. Chan
Chan married South African-born American billionaire...
- Abraxane
This scientific article needs additional citations to...
- Michele B. Chan
Dr. Patrick Soon-Shiong Executive Chairman and Global Chief Scientific and Medical Officer at ImmunityBio That fascination led him on the path to a distinguished career as a surgeon, scientist, inventor, and philanthropist with over 500 issued worldwide patents and 100 scientific publications.
Feb 7, 2018 · Patrick Soon-Shiong, a doctor turned entrepreneur who was born in South Africa to Chinese parents, has reached a deal to buy The Times and the San Diego Union-Tribune, a move that would shake...
People also ask
Who is Patrick Soon-Shiong?
Who is Soon-Shiong and what did he do?
Where was Soon-Shiong born?
Who is Dr Soon-Shiong?
Feb 7, 2018 · But Patrick Soon-Shiong, 65, a doctor who turned a cancer drug into a multibillion-dollar biotech empire, emerged on Wednesday as a major figure in Los Angeles life with his surprise $500...
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.
Jun 16, 2022 · Three decades after first writing about how natural killer cells (NK) functioned, Dr. Patrick Soon-Shiong, M.D., and his company, ImmunityBio, Inc. are on the final leg of what they hope will be U.S. Food and Drug Administration approval of their drug, N-803 (anktiva), for the treatment of bladder cancer.
Soon-Shiong performed the world’s first encapsulated human islet transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation’s first FDA approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer, doubling the response rate in patients.
